|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. Sci Rep. 2017 Sep 21;7(1):12066. doi: 10.1038/s41598-017-11683-2. PubMed PMID: 28935868; PubMed Central PMCID: PMC5608893.
AÑO: 2017; IF: 4.122
|
28935868
|
Roldán V, Rivera-Caravaca JM, Shantsila A, García-Fernández A, Esteve-Pastor MA, Vilchez JA, Romera M, Valdés M, Vicente V, Marín F, Lip GYH. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers. Ann Med. 2018 Feb;50(1):26-34. doi: 10.1080/07853890.2017.1378429. Epub 2017 Sep 18. PubMed PMID: 28892413.
AÑO: 2018; IF: 3.049
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project. Thromb Haemost. 2017 Oct 5;117(10):1848-1858. doi: 10.1160/TH17-07-0478. Epub 2017 Aug 11. PubMed PMID: 28799620.
AÑO: 2017; IF: 4.952
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores. J Am Heart Assoc. 2017 Jul 20;6(7). pii: e006490. doi: 10.1161/JAHA.117.006490. PubMed PMID: 28729407; PubMed Central PMCID: PMC5586327.
AÑO: 2017; IF: 4.45
|
|
Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Lip GYH. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opin Drug Saf. 2017 Sep;16(9):1051-1062. doi: 10.1080/14740338.2017.1351542. Epub 2017 Jul 12. Review. PubMed PMID: 28678553.
AÑO: 2017; IF: 3.156
|